Proliferative retinopathy in male and female patients with type 2 diabetes may predict coronary heart disease (CHD), but in women, background retinopathy predicted all-cause, cardiovascular disease, and CHD mortality, according to the results of a study.
Read More »New Oral Type 2 Drug Galvus as Effective as Avandia Without Wt. Gain
The second of a new class of oral antidiabetic drugs is able to lower blood sugar (glucose) in type 2 diabetes as well as Avandia (rosiglitazone) does, but without causing weight gain.
Read More »Boric Acid Beats Fluconazole for Candidiasis in Diabetics
Boric acid vaginal suppositories appear to be more effective than oral fluconazole in the treatment of diabetics with non-albicans Candida glabrata vulvovaginal candidiasis.
Read More »Drug-Eluting Stents Appear Superior to Bare Metal in Diabetics
Both paclitaxel- and sirolimus-eluting stents show “a trend toward more favorable outcome” in diabetics with occluded coronary arteries compared with bare-metal stents, Dutch investigators reported.
Read More »What Prevents Doctors from Counseling Their Patients to Lose Weight, Exercise, Q
Ninety-nine percent of doctors believe that part of their job is to encourage their patients to live a healthier lifestyle, but only 20% actually do it. Research at the University of Haifa addresses the question: why not?
Read More »Shedding Pounds from Diet or Exercise—Take Your Pick
People looking to lose those extra pounds have been told for decades that dieting together with exercise will bring about the best results. Not so, says new research.
Read More »Cause of Antipsychotic Drug Weight Gain Leading to Diabetes Found
Johns Hopkins brain scientists have hit on how and why some powerful drugs used for treating mental illnesses cause patients to gain so much weight that they often develop life-threatening complications such as diabetes and heart disease.
Read More »Nurse-led Diabetes Care Cuts Complications, Costs
Putting a nurse in charge of care for people with diabetes sharply reduces their need for urgent and emergency care, and reduces costs, a new study shows.
Read More »Diabetic Foot Infection Classification System Validated
The Infectious Diseases Society of America (IDSA) has designed a classification system for foot infections in patients with diabetes to provide better outcomes for these patients.
Read More »New Possible Drug for Neuropathic Pain
Preliminary results from a phase III withdrawal-design trial with lacosamide in patients with painful diabetic neuropathy show that lacosamide was statistically significant over placebo in reducing pain scores. SCHWARZ PHARMA plans for regulatory submission during the second half of 2007
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.